Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-01

Clinical Trial Update: Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis [Phase 4]

View source ↗

Summary

Phase 4 study evaluating safety and pharmacokinetics of efinaconazole topical solution in patients with mild to severe onychomycosis; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • efinaconazole topical solution (efinaconazole)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Onychomycosis | Phase 4 | Status: COMPLETED | Results posted: 2021-11-01